Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage i esophageal squamous cell carcinoma

American Journal of Gastroenterology

Volumn 106, Issue 6, 2011, Pages 1048-1054

  Yamamoto, Sachiko ^a   Ishihara, Ryu ^a   Motoori, Masaaki ^a   Kawaguchi, Yoshifumi ^a   Uedo, Noriya ^a   Takeuchi, Yoji ^a   Higashino, Koji ^a   Yano, Masahiko ^a   Nakamura, Satoaki ^a   Iishi, Hiroyasu ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANASTOMOSIS LEAKAGE; ANEMIA; ANOREXIA; ARTICLE; ATELECTASIS; BRAIN DISEASE; BRAIN INFARCTION; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CHYLOTHORAX; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; ENDOSCOPY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HAZARD RATIO; HUMAN; ILEUS; LEUKOPENIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NECROSIS; NEUTROPENIA; OVERALL SURVIVAL; PHARYNGITIS; PNEUMONIA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RECURRENT LARYNGEAL NERVE PALSY; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTOPENIA; TUMOR VOLUME; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79957975850     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.42     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
2. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-52. (Pubitemid 37485141)
3. Das A, Singh V, Fleischer DE et al. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 2008; 103: 1340-5. (Pubitemid 351813937)
4. The Japanese Society for Esophageal Diseases. Comprehensive registry of esophageal cancer in Japan (1998,1999, 3rd edn), The Japanese Society for Esophageal Diseases, Chiba, Japan, 2002.
5. Prasad GA, Wu TT, Wigle DA et al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology 2009; 137: 815-23.
6. Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 1998; 123: 432-9. (Pubitemid 28201225)
7. Ishihara R, Tanaka H, Iishi H et al. Long-term outcome of esophageal mucosal squamous cell carcinoma without lymphovascular involvement aft er endoscopic resection. Cancer 2008; 112: 2166-72. (Pubitemid 351628625)
8. Igaki H, Kato H, Tachimori Y et al. Clinicopathologic characteristics and survival of patients with clinical stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg 2001; 20: 1089-94. (Pubitemid 33051075)
9. Kato H, Sato A, Fukuda H et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 2009; 39: 638-43.
10. Walsh TN, Noonan N, Hollywood D et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7. (Pubitemid 26269945)
11. Tepper J, Krasna MJ, Niedzwiecki D et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008; 26: 1086-92.
12. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359: 1727-33.
13. Cunningham D, Allum W, Stenning SP et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
14. Birkmeyer JD, Siewers AE, Finlayson EV et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-37. (Pubitemid 34984604)
15. Chang AC, Ji H, Birkmeyer NJ et al. Outcomes aft er transhiatal and transthoracic esophagectomy for cancer. Ann Th orac Surg 2008; 85: 424-9.
16. Chan A, Wong A. Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma? Int J Radiat Oncol Biol Phys 1999; 45: 265-70. (Pubitemid 29408537)
17. May A, G ü nter E, Roth F et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 2004; 53: 634-40. (Pubitemid 38561439)
18. Dittler HJ, Pesarini AC, Siewert JR. Endoscopic classification of esophageal cancer: correlation with the T stage. Gastrointest Endosc 1992; 38: 662-8. (Pubitemid 23006379)
19. Kienle P, Buhl K, Kuntz C et al. Prospective comparison of endoscopy, endosonography and computed tomography for staging of tumours of the oesophagus and gastric cardia. Digestion 2002; 66: 230-6. (Pubitemid 36578773)
20. Trotti A, Colevas AD, Setser A et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003; 13: 176-81. (Pubitemid 36962641)
21. Kato H, Tachimori Y, Watanabe H et al. Superficial esophageal carcinoma. Surgical treatment and the results. Cancer 1990; 66: 2319-23.
22. Yamashita H, Okuma K, Seto Y et al. A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma. J Surg Oncol 2009; 100: 435-41.
23. Hironaka S, Ohtsu A, Boku N et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3) N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2003; 57: 425-33. (Pubitemid 37040939)
24. Ishihara R, Yamamoto S, Iishi H et al. Factors predictive of tumor recurrence and survival aft er initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys 2010; 76: 123-9.
25. Hattori S, Muto M, Ohtsu A et al. EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 2003; 58: 65-70. (Pubitemid 38208749)
26. Yano T, Muto M, Minashi K et al. Photodynamic therapy as salvage treatment for local failures aft er definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 2005; 62: 31-6. (Pubitemid 40922437)
27. Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009; 360: 2277-88.
28. Zhang YM, Bergman JJ, Weusten B et al. Radiofrequency ablation for early esophageal squamous cell neoplasia. Endoscopy 2010; 42: 327-33.
29. Minsky BD, Pajak TF, Ginsberg RJ et al. INT 0123 (Radiation Th erapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167-74. (Pubitemid 34177421)